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Background: Trisomy 1q and monosomy 3p deriving from a t(1;3) is an infrequent event. The clinical characteristics
of trisomy 1q41-qter have been described but there is not a delineation of the syndrome. The 3p25.3-pter
monosomy syndrome (MIM 613792) characteristics include low birth weight, microcephaly, psychomotor and
growth retardation and abnormal facies.
Case presentation: A 2 years 8 months Mexican mestizo male patient was evaluated due to a trisomy 1q and
monosomy 3p derived from a familial t(1;3)(q41;q26.3). Four female carriers of the balanced translocation and one
relative that may have been similarly affected as the proband were identified. The implicated chromosomal regions
were defined by microarray analysis, the patient had a trisomy 1q41-qter of 30.3 Mb in extension comprising
about 240 protein coding genes and a monosomy 3p26.3-pter of 1.7 Mb including only the genes CNTN6 (MIM
607220) and CHL1 (MIM 607416), which have been implicated in dendrite development. Their contribution to the
phenotype, regarding the definition of trisomy 1q41-qter and monosomy 3p26.3-pter syndromes are discussed.
Conclusion: We propose that a trisomy 1q41-qter syndrome should be considered in particular when the following
characteristics are present: postnatal growth delay, macrocephaly, wide fontanelle, triangular facies, frontal bossing,
thick eye brows, down slanting palpebral fissures, hypertelorism, flat nasal bridge, hypoplasic nostrils, long filtrum,
high palate, microretrognathia, ear abnormalities, neural abnormalities (in particular ventricular dilatation), psychomotor
developmental delay and mental retardation. Our patient showed most of these clinical characteristics with exception
of macrocephaly, possibly due to a compensatory effect by haploinsufficiency of the two genes lost from 3p. The
identification of carriers has important implications for genetic counseling as the risk of a new born with either a
der(3) or der(1) resulting from an adjacent-1 segregation is of 25% for each of them, as the products of adjacent-2 or
3:1 segregations are not expected to be viable.
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There are 14 patients reported with trisomy 1q and
monosomy 3p deriving from a t(1;3) which per se is an
infrequent event (Table 1) [1-7]. The clinical characteris-
tics of distal trisomy 1q syndrome have been described
in several cases but a precise characterization of the syn-
drome has not been achieved (Table 2) [8-21]. In this re-
gard, only 9 cases with a pure trisomy have been
reported [8,11,13,14,16-18,20], some of them correspond
to small interstitial duplications [14,16-18]; and in 5 of
them, a translocation with the short arm of an acrocen-
tric chromosome is implicated [8,11,13,20]. Other cases
are derived from an unbalanced translocation that have
a small monosomic segment from another chromosome
[9,10,12,15,19,21], additionally the proximal break pointTable 1 Clinical characteristics of patients with trisomy 1q an
Reference Yunis [1] Cook [2] Schinzel [3] McCart
1q trisomyc
segment/size
q32→qter q25→qter q32→qter q25→
3p monosomyc
segment/size
p25→pter p23→pter p25→pter p23→
Cytogenetic analyses K K K K
Patient P1 P 2 P 3 P 1 P
Origin de novo mat mat pat mat mat m
Gender F F M F M F M
Age 1 y NR NR NR 17y 8 m 20 y 19
Age at death NR NR NR NR NR - -
Hirsutism - NR NR NR + - -
Brachicephaly + NR NR NR - + N
Wide fontanelles + NR NR NR - NR N
CNSA NR NR NR NR + NR N
Abnormal EEC NR NR NR NR NR NR N
Abnormal face - + + + TF + +
TI + NR NR NR + NR N
Epicantal folding + NR NR NR + NR N
Hypertelorism + NR NR NR + NR N
OEA + - - - + - -
Nostrils - NR NR NR AN NR N
Long filtrum + NR NR NR - NR +
Narrow palate - NR NR NR + NR N
Micrognathia - NR NR NR - NR N
Dysmorphic ears + NR NR NR + + +
CHD - + + + - NR N
GTA - NR NR NR - - +
PD/MR + + + + + + +
aCGH: array Comparative Genomic Hybridization; AN: ANterverted; At B: At Birth; CH
EEC: Electroencephalogram; F: Female, FISH: Fluorescent in situ hybridization; GTA: G
Resolution Karyotype; K: Karyotype with banding techniques; M: Male; NR: Non Rep
Retardation; TF: Triangular Face TI: Temporal Indentation; VD: Ventricular Dilatation;varies between 1q41 [9,11,15,17,20,21] and 1q42
[8-12,14,18,19], but only two of them have been studied
by genomic methodologies [19,21] (Table 2).
Several cases of 3p25.3-pter monosomy syndrome
(MIM 613792) have been delineated (Table 3) [22-29].
The clinical manifestations of monosomy 3p syndrome
include low birth weight, microcephaly, trigonocephaly,
hypotonia, psychomotor and growth retardation, among
others (Table 3). Although intellectual deficits are almost
invariably associated with cytogenetically visible 3p dele-
tions, patients with infrequent 3p25-p26 or terminal de-
letions display normal intelligence or mild abnormalities
[26,27,30]. A critical region has been identified for
monosomy 3p and several genes have been proposed
as responsible for the phenotypic features [24,25,30],d monosomy 3p derived from t(1;3)
hy [4] Sunaga [5] Kozma [6] Li [7] Our study








HRK HRK, FISH K, aCGH K, FISH,
HDMA
2 P 3 P 1 P 2 P 1 P 2 P 3
at pat mat mat pat mat mat mat mat
F M M F F M M M
y 18y 6 y 4 y 3 wks At B At B At B 2y 8 m
- - - 3 wks 16 m 9 y 9 m -
- - - - - - + +
R NR NR NR + - - - +
R NR NR NR + - - + -
R NR VD VD + + - VD VD
R NR + - + + + + +
+ - - TF TF TF - +
R NR + + - - - + +
R NR + + - - - NR -
R NR + + + + + NR +
+ + + + + + + +
R NR AN - - AN AN AN AN
NR + + + + + - +
R NR + + + NR NR - +
R NR + + + + + + +
- + + + + + + +
R NR - - + + - + -
- - - - - + + -
+ + + + + + + +
D: Congenital Heart Disease; CNSA: Central Nervous System Abnormalities;
enitourinary Track Anomalies; HDMA: high density microarray; HRK: High
orted; OEA: Other Eye Abnormalities; PD/MR: Psychomotor Delay/Mental
wks: weeks; y: years, m: months; +: feature present; -: feature absent.


























































































K K K K K K K, FISH K, FISH K,
FISH,
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Origin mat pat mat pat mat pat pat de novo mat de
novo
de novo de novo NR de
novo
de novo de novo mat mat
Gender M F F M M M F/M F F F F M F F M M M M
Age At
birth
1 m 21 m 2y 7y
5 m
5y 1 m 22y/21y 6 m 5y 2y
3 m
11y 5y 1y 8 m 4y
9 m
1y 11y 6 m 2y 8 m
PGD NA - + + - + 2/2 - - - + + + + NR - + +
Macrocephaly + + -q + + -q 2/2 + + + + + -q + + + + -
Wide
fontanelles









- - + + - + 2/2 + - + - + NR + + + + +
Frontal
bossing
+ + + + + + 2/2 + + + + + NR + + + + +
T, DS eye
brows
+ - - + - - 2/2 - - - - NR + - + - - +
DSPF - + + - + - 2/2 + - + + NR + - + + - -
Ptosis - - + - + - 0/2 - - - - NR - - + - NR +
Hypertelorism - - + - + - 0/2 - + - - + + + NR + NR +
OEA NR + - - + - 0/2 NR - + - NR - - + - NR +
Broad nasal
bridge
+ - - + - - 0/2 - - + + NR - - + - + +
Hypoplasic
nostrils
- - - + + - 0/2 - - - - NR + - - + - -
Long Filtrum + + - + + - 0/2 + - - - + - + + - - +
High palate NR + + + BU NR +/- NR - + - NR + NR NR + NR +
Micro/
retrognathia





















Table 2 Clinical characteristics of patients with distal trisomy 1q (Continued)
Dysmorphic
ears
+ + - + + NR 0/2 - - - - NR + + + + + +
CHD + - - + - - +/- - + + - + + - + - - -
GTA - NR NR + - - -/+ - + - - NR NR - + - - -
Limb
abnormalities
- - + + + + +/- - - + + NR + + + + NR +
CH + + - + - - 0/2 + - - - NR NR NR NR NR - -
PD/MR NA + + + + + 2/2 + - + + + + + + + + +
Abnormal
Language
NA + NR + + NR NR NA NR + - NR + NR NR + NR +
a: 46,XY,der(22)t(1;22)(q42;p12); b: 46,XX,der(10)t(1;10)(q41;q26); c: 46,XX,der(13)t(1;13)(q42;q34); d: 46,XY,der(4)t(1;4)(q41;q34); e: 46,XY,der(4)t(1;4)(q42;q35); f: 46,XY,der(15)t(1;15)(q42;qter); g: 46,XX,der(15)t(1;15)(q42,1;
p11.1); h: 46,XX,der(8)t(1;8)(q42.2;p23.3) at amniocentesis; i: 46,XX,der(15)t(1;15)(q44;p12); j: 46,XX,dup(1)(q44q42), k: 46,XX,der(8)t(1;8)(q41;p23.3) l: 46,XX,inv dup(1)(q41-q44); m: 46,XY,der(9)t(1;9)(qter-q41::q34.3-pter);
n: 46,XY,der(13)t(1;13)(q41;p12) o: 46,XY,der(11)t(1;11)(q41;p15.5)mat; p: 46,XY,der(3)t(1;3)(q41;p26.3); q: microcephaly; aCGH: Array Comparative Genomic Hybridization; BU: Bifid Uvula; CA: Cortical Atrophy; CH: Capillary
Hemangiomas; CHD: Congenital Heart Disease; CNSA: Central Nervous System Abnormalities; DSPF: Down Slanting Palpebral Fissures; F: Female; FISH: Fluorescent in situ hybridization; GTA: Genitourinary Track
Abnormalities; HDMA: high density microarray; K: Karyotype with banding techniques; M: Male, m: months; mat: maternal; MCB: MultiColor Banding; PD/MR: Psychomotor Delay/Mental Retardation; NA: Non Applicable;
NR: Non Reported; OEA: Other Eye Abnormalities; pat: paternal; PMM: Polymorphic Microsatellite Markers; PGD: Postnatal Growth Delay; T/DS: Thick/Down Slanting; VD: Ventricular Dilatation; y: years; WCM: Wide
























































































Origin de novo de novo de novo de novo de novo de novo de novo mate matf patg de novo NR mat
Gender M M F NR NR NR NR M M M/M F F M
Age 7y 11 m 5y 6 m 4y NR NR NR NR 12y 12y 9y/7y 24wg 22y † 2y 8 m
PGD + + - NR NR NR NR - + 0/2 NA + +
Hypotonia + - + NR NR NR NR + - 0/2 NA - +
Hirsutism + - - NR NR NR NR - - 0/2 NR - +
Microcephaly - + + NR 2/9 + NR - + 0/2 NR + -
CNSA - - + NR NR NR NR - - 1/2 - + +
Triangular face - + - NR NR NR NR -g - 0/2 NR + +
DSPF + + - NR NR NR NR - - 0/2 NR + -
Ptosis + - + NR 2/9 + NR - - 0/2 NR + +
Hypertelorism + + + NR NR NR NR - - 0/2 + - +
OEA + NR + NR NR NR NR - - 1/2 NR + +
Broad nasal
bridge
+ + + NR NR NR NR + - 0/2 NR + +
Hypoplasic
nostrils
- + - NR NR NR NR - - 0/2 NR - -
High or cleft
palate
- + - NR NR NR NR + - 0/2 NR + +
Micrognathia - + - NR 2/9 NR NR - - 0/2 + - +
Dysmorphic ears + + + NR NR NR NR + - 0/2 + + +
CHD - - + 3/3 2/9 - - - - 0/2 - + -
GTA - + - NR NR NR NR - - 0/2 NR - -
Limb
abnormalities





















Table 3 Clinical characteristics of patients with monosomy 3p with different break points and sizes (Continued)
PD/MR BL + + 3/3 9/9 + - LD LD BL/- NA + +
Abnormal
Language
+ + + NR NR NR NR + + 2/2 NA + +
Seizures - + + NR NR NR - - - 1/2 NA + +
a: 46,XY,t(3;10)(p26;q26), disruption of CNTN4; b: 45,XY,der(3)t(3;13)(p26.2;q12.13),-13; c: In vitro fertilization; d: amniocentesis and pregnancy interruption; e: mother and sister with the same deletion; f: mother with the
same deletion without clinical data and mildly dysmorphic features; g: father with same deletion and no clinical data; h: asymmetric face; aCGH: array Comparative Genomic Hybridization; BL: BorderLine; DSPF: Down
Slating Palpebral Fissures; F: Female; FISH: Fluorescent in situ hybridization; GTA: Genitourinary Track Anomalies; HDMA: high density microarray; K: Karyotype with banding techniques; LD: Learning Disability; M: Male;
m: months; NA: Not Applicable; NR: No Reported; SEQ: sequencing of candidate genes; PD/MR: Psychomotor Delay/Mental Retardation; PGD: Postnatal Growth Delay; QF-PCR: Quantitative Fluorescent-PCR; SNPa: Single
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been identified for terminal trisomy 1q syndrome
[12,20,21,31]. We report the case of a patient with a tri-
somy 1q and monosomy 3p derived from a familial t
(1;3)(q41;q26.3). The chromosomal regions involved
were defined by high-density microarray techniques and
their effects in the phenotype regarding the definition of
the syndromes are discussed.
Case presentation
Clinical report
The proband is a 2 years 8 months Mexican mestizo
male (Figure 1, IV.1), first known at 4 months of age
due to dysmorphic features and mental development ar-
rest. He is the only child of a young, apparently healthy
and unrelated couple. He had two maternal uncles who
died during childhood and presented congenital diseases,
one of them also had dysmorphic features. The preg-
nancy was 38 weeks long and was complicated by a
threat of miscarriage in the first trimester. His weight
was 2,880gr (P10), height 51 cm (P50), and Apgar score
8/9. He could sit without support at 12 months of age;
however so far he has not achieved speech, cannot walk
and does not control sphincters. He suffered from esopha-
geal reflux at 5 months of age, pneumonia at 8 months and
was treated for dacryostenosis at 12 months. At present he
has a weight of 11 kg (<P5), height 84 cm (<P5) and head
circumference of 48 cm (P25). He has brachicephaly, tri-
angular facies, horizontal palpebral fissures, micrognathia
and several dysmorphic features, low set and retropositionFigure 1 Pedigree of the family.of the ears, widely spaced nipples and hypotrophic limbs
(Figure 2 and Tables 1, 2 and 3). Heart and renal malforma-
tions were discarded. The MRI showed ventriculomegaly
and a subarachnoid cyst.
Cytogenetic analysis
The GTG banding demonstrated additional material on
3p26.3 in the proband (Figure 3A), the karyotype of the
mother (Figure 1, III.6) revealed a balanced translocation
between chromosomes 1 and 3 (Figure 3B), also present
in other three female family members (Figure 1) with a
chromosomal complement 46,XX,t(1;3)(q41;p26.3). FISH
analyses using subtelomeric probes (ToTelVysion™, Vysis
Abbott, Inc. Abbott Park, IL, USA), mixture 1:1p
(CEB108/T7, green), 1q (D1S3738, orange) and mixture
3: 3p (D3S4559, green), 3q (D3S4560, orange) confirmed
the presence of the derivative chromosome 3 in the pro-
band and showed the balanced translocation in his
mother. Additionaly, mixture 1 includes Xp/Yp (yellow)
and centromeric X (aqua) probes, while mixture 3
contains probes 22q (yellow) and BCR (aqua) (Figure 3C




559-,D3S4560+) for his mother.
Microarray analysis
Genomic DNA was extracted from a peripheral blood
sample. Copy-number analysis was performed using the
Figure 2 Facial characteristics of the proband are shown. A) Frontal view: triangular face and horizontal palpebral fissures. B) Lateral view:
micrognathia, and posteriorly rotated low set ears.
Figure 3 Cytogenetic analysis. A. Partial karyotype of the proband showing additional material in 3p26.3. B. Partial karyotype of mother’s
patient (individual III.6) showing a balanced t(1;3)(q41;p26.3). C. FISH analysis in patient’s metaphase showing a der(3) with both subtelomeric
probes 1q and 3q in orange (the arrow indicates the der(3) and normal chromosomes 1 and 3 are indicated). D. FISH analysis in a metaphase of
individual III.6 showing a balanced translocation, the der(1) with subtelomeric 1p and 3p probes both in green and the der(3) with 1q and 3q
probes in orange are indicated with arrows, the normal chromosomes 1 and 3 are also indicated.
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CA, USA). Data was analyzed with Chromosome Ana-
lysis Suite 2.0 (Affymetrix Inc.), using 50 markers and
200 kb resolution. Joining algorithm was applied for
copy-number altered segments interrupted by <200 kb
normal state data. Mapping was based on the human
genome assembly Feb 2009 (GRCh 37/hg19). The analysis
on the proband revealed a chromosome 1q41-qter dupli-
cation (pos.218,920,024-249,224,684) and a chromosome
3pter-p26.3 deletion (pos.61,891-1,774,215) (Figure 4).
In addition, a 640 kb duplication was detected on
chromosome 14q32.33 (pos.106,072,250-106,712,665),Figure 4 Microarray analysis. A. The 30.3 Mb duplication in 1q41-qter an
microarray mapping. The solid bars at the top of each panel indicate the c
the bottom. The chromosome scheme at the left of each panel is not to scthis alteration corresponds to a highly represented
CNV region, according to the Database of Genomic
Variants [32,33].
Discussion
The patient described in this report has a trisomy 1q41-
qter of 30.3 Mb in extension (comprising about 240 pro-
tein coding genes) and has a monosomy 3p26.3-pter of
only 1.7 Mb. These break points are similar to those
found in at least 6 reported cases with der(3)t(1;3)
(Table 1) [5-7]. It is interesting to note that 14 patients
have been described with trisomy 1q and monosomy 3p,d B. The 1.71 Mb deletion in 3p26.3-pter identified on the proband by
opy-number altered regions and chromosome bands are annotated at
ale.
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techniques (aCGH) [7]. The case reported here has been
addressed by high-density microarray analysis, and re-
vealed different break points and chromosomal segment
sizes than the previously published. We consider that
our patient shows a phenotype that resembles trisomy
1q41-qter syndrome, as he has brachicephaly, triangular
face, temporal indentation, hypertelorism, anteverted
nostrils, low set and malformed ears, micrognathia and
narrow palate, all of which are features of distal trisomy
1q syndrome [34]. Despite this, we consider that the
small deleted region at chromosome 3p could be modi-
fying the phenotype of our patient. For example, head
circumference data reported for trisomy 1q shows that
most of the patients (82%) have macrocephaly (Table 2)
while pure monosomy 3p patients have microcephaly
more frequently (53-70%) (Table 3). In this regard, our
patient displayed normal head circumference, and con-
sidering the specific chromosomal regions implicated in
this phenotype and therefore the genes within these loci
(Table 2), it seems that macrocephaly is associated to a
duplicated region close to or in 1q43 [13,14,16-19]. Re-
cently, 1q43 has been proposed as a candidate region for
microcephaly, in particular AKT3 has been considered
as a candidate gene for this feature in patients with a
microdeletion of 1q43-q44 [35]. On the other hand, ac-
cording to the described patients with monosomy 3p,
both proximal and distal deletions to 3p26 show micro-
cephaly and so far a critical region has not been identi-
fied [24-26,29]. Although this characteristic in neither of
the two pure syndromes is always present, it is possible
that a compensatory effect of both implicated regions
could be taking place in our patient and, as observed in
other patients with a der(3) of a t(1;3) (Table 1), he has
not macro or microcephaly but he has brachicephaly.
However, these malformations may be multifactorial in
their etiology.
The specific effect of each of the chromosomal regions
regarding a particular clinical characteristic cannot be
extended to all the features in the patient reported here
or in the previously described patients, as this analysis is
further complicated by: 1) the precise loci involved, 2)
the size of the chromosomal fragments implicated in
both the translocations and the pure trisomy 1q and
monosomy 3p, and 3) the number and function of the
genes present. As a result, most of the alterations of the
diverse cases are privative of a given patient. When con-
sidering the first eight cases reported with a der(3)t(1;3)
(Table 1) [1-4], 50% have break points with a longer
chromosome fragment implicated than in our patient. In
fact, the patients with a more similar phenotype to our
patient are the ones reported by Sunaga et al., [5] which
have break points in 1q42 and 3p26. However, not even
in these cases the similarity is complete as these patientsshow the brachicephaly and abnormalities of the neural
central system (that similar to our case, one of them is
ventricular dilatation). All these patients show a triangu-
lar face and temporal indentation, but they do not show
hirsutism, while some other characteristics are not con-
stant among the three cases (Table 1) [5]. Another inter-
esting consideration is that these patients do not have
congenital heart disease and all of them have mental
retardation. A critical region for congenital heart disease
has been designated to a 0.65 Mb region in 3p25 and four
candidate genes have been proposed: SLC6A1 (MIM
137165), HRH1 (MIM 600167), ATG7 (MIM 608760) and
CRELD1 (MIM 607170) [24,25,30]. This region is not im-
plicated in our case (Tables 1 and 3) and this may explain
why even though both chromosomal abnormalities involve
heart disease, our case does not show this characteristic.
Only a third of the patients with terminal trisomy 1q have
congenital heart disease and apparently, there is not a crit-
ical region for this malformation (Table 2) [8,9,11,13,16,17].
Microarray analysis on our patient demonstrated that
two genes, CNTN6 (MIM 607220) and CHL1 (MIM
607416) (which has been previously implicated in neur-
onal development associated to dendrite migration and
mental retardation), are located within the deleted re-
gion and might implicate an haploinsufficiency mechan-
ism, as loss of these genes has been related to mild
mental deficit or do not present symptoms at all [26,27].
Studies about CNTN4 (MIM 607280) indicate that it be-
longs to the same family as CNTN6. In a patient de-
scribed by Fernandez et al., [22], CNTN4 was disrupted
by a balanced translocation, while the patient displayed
severe clinical manifestations associated to monosomy
3p (in particular the facial features without triangular
face or microcephaly) and mental retardation. Assuming
that even if no chromosomal material was gain or lost in
the case referred, CNTN4 is an important gene for brain
development. Therefore, it has been considered that
CNTN4 corresponds to the critical region or is one crit-
ical gene for the monosomy 3p clinical characteristics.
In our patient, CNTN4 is not included in the deleted re-
gion as it is further centromeric, however CNTN6 is
deleted and, considering that it belongs to the same gene
family, its effect should not be underestimated. In
addition, studies by Mercati et al., [36] have shown that
CNTN6 is implicated in the same pathway as CHL1, i.e.
the integrity of the neuronal development. CHL1 gene
participates in brain development, interacting with a tyr-
osin phosphatase protein, regulating its activity in the
complex signaling of the neuronal dendritic migration.
Therefore, its deletion may have an important role in
the mental retardation observed in our patient, and
although its importance is difficult to assess, as in the
patients described by Pohjola et al., [26] and Couco
et al., [27] in whom these genes are lost, some of them
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are apparently normal. It is possible that in our patient, due
to the presence of the trisomy 1q41-qter, the haploinsuffi-
ciency of both genes could have a synergic effect that in
turn compromises the psychomotor development.
Analysis of the phenotypic impact that the chromo-
some 1q trisomy region may have on our patient is com-
plicated by the fact that over 240 genes may be involved,
and in general terms the additive effect of these genes
may be related to the facial, cranial and cognitive abnor-
malities (Table 2). Although several cases with similar
chromosomal abnormalities have been described, the
contribution of specific regions in the development of
the characteristics of the syndrome is not clear, due to:
1) the high number of genes implicated, 2) the variability
of the break points and 3) the fact that not all of the
cases correspond to pure terminal trisomies. Therefore,
a trisomy 1q41-qter syndrome should be considered in
particular when the following characteristics are present:
postnatal growth delay, macrocephaly, wide fontanelle,
triangular face, frontal bossing, thick eye brows, down
slanting palpebral fissures, hypertelorism, flat nasal bridge,
hypoplasic nostrils, long filtrum, high palate, microretrog-
nathia, ear abnormalities, neural abnormalities (in particu-
lar ventricular dilatation), psychomotor delay and mental
retardation (Table 2).
In the 1q41-q42 region are the loci for 5S rRNA and
this situation may predispose to chromosomal rear-
rangements, in particular with the short arms of
acrocentric chromosomes during the transcription of
ribosomal genes [37]. This is illustrated in Table 1, as in
5 out of 9 cases with pure 1q trisomy, this region is im-
plicated [8,11,13,20]. Furthermore, recently a new case
of trisomy 1q41-qter has been described in a patient
who also has a partial trisomy 9pter-9q21.32, derived
from a 3:1 segregation of a maternal balanced transloca-
tion, and it has been suggested that the break-point is
associated with the presence of a fragile site (FRA1H) lo-
calized to 1q41-q42.1 [38].
The chromosomal analysis of our family revealed 4 fe-
male carriers of the balanced translocation (Figure 1)
and this has an important implication for genetic counsel-
ing. The pedigree shows 5 cases of spontaneous abortions,
which might have resulted from an adjacent-1 segregation.
There is also an uncle of the proband (Figure 1, III.11) that
was described with psychomotor delay and dysmorphic fea-
tures, and who died in infancy of unknown causes. We may
suppose that this person had a der(3)t(1;3) resulting of
adjacent-1 segregation, as with the proband. When consid-
ering the segregation of the chromosomes implicated in the
translocation, the risk of a newborn with either a der(3) or
der(1) resulting from an adjacent-1 segregation is of 25%
for each of them, as the products of adjacent-2 or 3:1 segre-
gations are not expected to be viable.Conclusion
The case described here gives new insights into the com-
plex definition of distal trisomy 1q and monosomy 3p26.3
syndromes. Even though in this case the trisomy affects
such a large quantity of genes, it is possible to evaluate the
clinical characteristics in order to understand their partici-
pation in the pathogenesis of the syndrome and has very
important implications for the genetic assessment.
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